Dr Lalchandani Labs Share Price

This is with reference to our prior intimation dated December 16 2025 wherein we had informed the Exchange about the meeting of the Board of Directors of Dr Lalchandani Labs Limited (the Company) scheduled to be held on Monday December 22 2025 inter alia to consider and approve matters relating to the proposed Rights Issue including fixation of the record date issue price entitlement ratio and other related terms.We wish to inform you that the aforesaid Board Meeting scheduled to be held on December 22 2025 has been deferred due to the non-receipt of In-Principle Approval from BSE Limited for the proposed Rights Issue.

Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2025 inter alia to consider and approve fixation of the record date;? determination of the issue price;? determination of the rights entitlement ratio; and? such other terms and conditions as may be required in accordance with applicable laws subject to receipt of necessary statutory and regulatory approvals.

Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholders as on record date (to be determined and specified subsequently)

Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 433.31 Lakhs to the eligible equity shareholders of the Company as on the record date (to be determined and notified subsequently) subject to receipt of statutory / regulatory approvals in accordance with the amended SEBI (Issuer of Capital and Disclosure Requirements) Amendment Regulations 2025 (the SEBI ICDR Regulations) and other applicable regulations and subject to necessary approvals as may be required.

Outcome of Board Meeting